Amar Gupta

This inventor holds 45 USPTO granted patents and 4 published patent applications, plus 8 CIPO patents and 17 EPO patents, primarily in Nucleic Acid Analysis. Top assignees: Roche Molecular Systems, Inc., Nokia Corporation, Network Equipment Technologies, Inc.. Active years: 1995-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amar Gupta. Retrieved from https://idiyas.com/inventor/amar-gupta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 45 (Patent Applications = 4)

% Patents Active = 80.0

CIPO Patents = 8

EPO Patents = 17 (Patent Applications = 8)

Average Co-Inventor Count = 2.6

ph-index = 13

Forward Citations = 803(Granted Patents)

Location History:

Cupertino, CA (US) (1995 - 2008)
Danville, CA (US) (2007 - 2022)

Company Filing History:

34 out of 646

Roche Molecular Systems, Inc.

Network Equipment Technologies, Inc.

Cisco Technology, Inc.

patents

Years Active: 1995-2022

Loading Chart...

Areas of Expertise:

Multiplexed PCR

Nucleotide Reagents

RNA Stabilization

Nucleic Acid Detection

Fluorescent Labels

Mutation Detection

Oligonucleotide Synthesis

Probe Analysis

Target Identification

Thermal Stability

Contamination Prevention

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11345958 - Methods for performing multiplexed real-time PCR (2022-05-31),

2. 11198903 - Methods for performing multiplexed real-time PCR (2021-12-14),

3. 11078534 - Photocleavable nucleotide reagents with high stability (2021-08-03),

4. 11034997 - Methods for performing multiplexed real-time PCR (2021-06-15),

5. 11028433 - Methods for performing multiplexed PCR (2021-06-08),

6. 10793901 - Reversibly protected nucleotide reagents with high thermal stability (2020-10-06),

7. 10689689 - Generic method for the stabilization of specific RNA (2020-06-23),

8. 10590469 - Methods for performing multiplexed real-time PCR in a self-contained nucleic acid analysis pouch (2020-03-17),

9. 10106842 - Nucleic acid target identification by structure based probe cleavage (2018-10-23),

10. 9873908 - Methods for the enrichment of mutated nucleic acid from a mixture (2018-01-23),

11. 9828629 - Nucleic acid target identification by structure based probe cleavage (2017-11-28),

12. 9637791 - Multiplexed nucleic acid target identification by strucutre based probe cleavage (2017-05-02),

13. 9279146 - Compounds and methods for the enrichment of mutated nucleic acid from a mixture (2016-03-08),

14. 9206476 - Sequencing and genotyping using reversibly terminating nucleotides (2015-12-08),

15. 8669061 - Method for the prevention of carryover contamination in nucleic acid amplification technologies (2014-03-11),

Title: Innovator Spotlight: Amar Gupta - Pioneering Advances in PCR Technology

Introduction: Amar Gupta, a distinguished inventor based in Danville, CA, has garnered a reputation for his groundbreaking work in the field of real-time PCR technology. With an impressive portfolio of 34 patents, he continues to push the boundaries of innovation at Roche Molecular Systems, Inc.

Latest Patents: Among his recent patents, Amar Gupta has introduced cutting-edge methods for performing multiplexed real-time PCR. These techniques enable the detection and quantitation of target nucleic acids using tagged hydrolysis probes, advancing the capabilities of PCR technology.

Career Highlights: Amar Gupta's career is marked by a relentless pursuit of excellence in molecular diagnostics. His contributions have not only expanded the possibilities in PCR methodology but have also enhanced the precision and efficiency of nucleic acid analysis.

Collaborations: Alongside accomplished colleagues such as Stephen Gordon Will and Veeraiah Bodepudi, Amar Gupta has fostered a collaborative environment that nurtures innovation. Together, they have propelled Roche Molecular Systems, Inc. to the forefront of molecular diagnostics research.

Conclusion: Amar Gupta stands as a luminary in the realm of molecular diagnostics, with his pioneering work paving the way for transformative advancements in PCR technology. His dedication to innovation and his collaborative spirit continue to inspire breakthroughs in the field.

Profile summary based on public USPTO records.